Which patients does the American College of Chest Physicians (ACCP) recommend the use of incentive spirometry (IS), EzPAP, or Acapella (oscillating positive expiratory pressure device) in?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ACCP Does Not Provide Specific Recommendations for IS, EzPAP, or Acapella

The American College of Chest Physicians (ACCP) does not have published guidelines specifically recommending incentive spirometry (IS), EzPAP, or Acapella devices for any patient population. The available ACCP evidence addresses these devices only in the context of chronic cough due to bronchiectasis, where bronchopulmonary hygiene techniques are discussed generally without device-specific recommendations 1.

What the ACCP Actually Says

Bronchiectasis Patients

In their 2006 bronchiectasis guidelines, the ACCP recommends:

  • Chest physiotherapy should be used in patients with conditions associated with hypersecretion of mucus and inability to expectorate effectively 1
  • Patients should be monitored for symptom improvement
  • This is a weak recommendation based on expert opinion (Grade E/C)

The ACCP does not specify which devices or techniques to use—they simply acknowledge that bronchopulmonary hygiene techniques (including chest percussion, vibration, postural drainage, mechanically assisted cough, and airway oscillation) are commonly used but have only modest effects on increasing sputum volume with unknown long-term effectiveness 1.

What Other Guidelines Say

British Thoracic Society (More Specific)

The BTS 2019 bronchiectasis guideline provides more detailed airway clearance recommendations 2:

  • Active Cycle of Breathing Techniques (ACBT) is the most commonly taught technique (91% of UK physiotherapists use it routinely)
  • ACBT is as effective as oscillating PEP devices for sputum clearance
  • Oscillating PEP devices like Acapella are used much less frequently than ACBT
  • During exacerbations, patients should be seen daily by a respiratory physiotherapist until airway clearance is optimized

Post-Surgical Context

For pulmonary lobectomy, the 2021 French guidelines found 3:

  • Multimodal physiotherapy (early mobilization, walking, breathing exercises, coughing techniques) is recommended
  • Adding incentive spirometry or vibratory expiratory pressure devices (like Acapella) to standard multimodal management showed no additional benefit
  • These isolated techniques should not be applied alone

Clinical Context from Research

Recent studies show:

  • EzPAP and Acapella are comparable to IS for post-surgical lung expansion 4, 5
  • OPEP devices may improve spirometry and exercise capacity in stable COPD when added to standard therapy 6
  • EzPAP may be comparable to NIV for COPD exacerbations in emergency settings 7

Common Pitfalls

  1. Assuming ACCP has device-specific recommendations: They don't. Their guidance is general about airway clearance techniques
  2. Using these devices in isolation: Evidence suggests multimodal approaches are superior
  3. Applying bronchiectasis recommendations to other conditions: The limited ACCP guidance is specific to mucus hypersecretion with impaired expectoration

Bottom Line

If you need device-specific guidance, refer to the British Thoracic Society guidelines for bronchiectasis 2 or surgical recovery guidelines 3, not ACCP. The ACCP's position is simply that some form of bronchopulmonary hygiene should be used in patients who cannot clear secretions effectively, without mandating specific devices 1.

Related Questions

Is requiring incentive spirometry, EzPAP (positive airway pressure device), and Acapella (airway clearance device) for all patients breathing room air without a history of respiratory disease medically justified, or could it constitute Medicare fraud?
In a stable asthmatic patient with an occasional non‑productive cough, is routine use of incentive spirometry, ezPAP (expiratory positive airway pressure), or Acapella (vibratory clearance device) indicated?
Does the medical literature support the use of the EzPAP (positive airway pressure) system to improve lung expansion and prevent adverse clinical outcomes or exacerbations of comorbidities?
Is it appropriate to prescribe EzPAP (EzPAP device) for all residents in a skilled‑nursing or long‑term‑care facility as a blanket preventive measure regardless of diagnosis, and can it be billed under Medicare Part A?
Should incentive spirometry, ezPAP (expiratory positive airway pressure), or Acapella (vibratory airway clearance device) be used routinely for a general skilled nursing facility or long‑term care patient population who are breathing room air, have no history of pulmonary disease, and are only limited by reduced activity?
Should patients be given albuterol before using a cough assist device or an oscillatory vest?
In a large population study of breast cancer patients where overall mortality is 15.9% from cardiovascular disease and 15.1% from breast cancer, what are the age‑specific and stage‑specific percentages of deaths attributable to cardiovascular disease versus breast cancer?
In a patient with hematuria, should low‑molecular‑weight heparin (LMWH) be discontinued?
What are the common brand names for lorazepam?
Which antipsychotic medications are most commonly prescribed, listed in order of prevalence?
In a 32-year-old pregnant woman presenting with knee swelling suggestive of arthritis, what are the differential diagnoses?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.